跳至主要内容
临床试验/JPRN-UMIN000030828
JPRN-UMIN000030828招募中未知

The preventive effect for new vertebral fractures of zoledronic acid and denosumab combined with vitamin D in patients with rheumatoid arthritis. - EVIDENCE study

Osaka City University Graduate School of Medicine0 个研究点目标入组 500 人开始时间: 2018年1月15日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) The patients with contraindication to denosumab and bisphosphonate 2) The patients who used zoledronic acid or denosumab previously 3) The patients who used teriparatide previously 4) The patients who are not included other intervention study 7) Those who are not approved to be eligible to this study by corresponding researcher

研究者

发起方
Osaka City University Graduate School of Medicine

相似试验

The preventive effect for new vertebral fractures of... | 临床试验